Anti-platelet therapy reduces the incidence of hepatocellular carcinoma in patients with chronic hepatitis B

被引：0
|
作者：
Lee, Minjong [2 ,3 ]
Lee, Jeong-Hoon [2 ,3 ]
Oh, Sohee [1 ]
Chang, Young [2 ,3 ]
Nam, Joon Yeul [2 ,3 ]
Cho, Young Youn [2 ,3 ]
Yoo, Jeong-Ju [2 ,3 ]
Cho, Yuri [2 ,3 ]
Lee, Donghyeon [2 ,3 ]
Cho, Eun Ju [2 ,3 ]
Yu, Su Jong [2 ,3 ]
Kim, Yoon Jun [2 ,3 ]
Yoon, Jung-Hwan [2 ,3 ]
机构：
[1] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Biostat, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
[3] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1610
引用
收藏
页码：995A / 995A
页数：1
相关论文
共 50 条
  • [1] Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma
    Sitia, Giovanni
    Iannacone, Matteo
    Guidotti, Luca G.
    JOURNAL OF HEPATOLOGY, 2013, 59 (05) : 1135 - 1138
  • [2] Entecavir reduces the incidence of hepatocellular carcinoma in patients with chronic hepatitis B
    Yasunaka, Tetsuya
    Ikeda, Fusao
    Takaki, Akinobu
    Seno, Tomonori
    Takaguchi, Koichi
    Yamamoto, Kazuhide
    HEPATOLOGY, 2014, 60 : 1096A - 1096A
  • [3] Chronic hepatitis B: role of anti-platelet therapy in inflammation control
    Roberto Aiolfi
    Giovanni Sitia
    Cellular & Molecular Immunology, 2015, 12 : 264 - 268
  • [4] Chronic hepatitis B: role of anti-platelet therapy in inflammation control
    Aiolfi, Roberto
    Sitia, Giovanni
    CELLULAR & MOLECULAR IMMUNOLOGY, 2015, 12 (03) : 264 - 268
  • [5] ASPIRIN REDUCES THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN ETVTDF TREATED PATIENTS WITH CHRONIC HEPATITIS B
    Hui, Vicki Wing-Ki
    HEPATOLOGY, 2020, 72 : 453A - 454A
  • [6] Tenofovir-based antiviral therapy reduces long-term incidence of hepatocellular carcinoma in chronic hepatitis B patients
    Kim, W. Ray
    Lim, Young-Suk
    Janssen, Harry L. A.
    Ahn, Sang Hoon
    Jacobson, Ira
    Mizokami, Masashi
    Wong, Grace
    Abramov, Frida
    Yee, Leland J.
    Wang, Hongyuan
    Frenette, Catherine
    Flaherty, John F.
    Fung, Scott K.
    Marcellin, Patrick
    Seto, Wai-Kay
    Agarwal, Kosh
    Hou, Jinlin
    Lim, Seng Gee
    Kao, Jia-Horng
    Buti, Maria
    JOURNAL OF HEPATOLOGY, 2024, 80 : S797 - S797
  • [7] Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with chronic hepatitis B
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Kobayashi, Masahiro
    Seko, Yuya
    Kawamura, Yusuke
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    HEPATOLOGY, 2012, 56 : 366A - 366A
  • [8] Thrombocytopenia and anti-platelet antibodies in patients with chronic hepatitis C
    Pshenichnaya, N.
    Gopatza, G.
    Zhuravlev, A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 45 : 453 - 453
  • [9] National reimbursement for chronic hepatitis B therapy and incidence of hepatocellular carcinoma in Taiwan
    Wu, Jaw-Ching
    Wu, Chun-Ying
    HEPATOLOGY, 2012, 56 : 388A - 389A
  • [10] Incidence of hepatocellular carcinoma in chronic infection with hepatitis B
    Ntagirabiri, Renovat
    Munezero, Belyse
    Kaze, Hippolyte
    Ndirahisha, Eugene
    Manirakiza, Sebastien
    PAN AFRICAN MEDICAL JOURNAL, 2015, 20
12345